Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial
一项随机双盲对照临床试验结果表明,在难治性类风湿性关节炎的治疗中,来氟米特与低剂量利妥昔单抗联合甲氨蝶呤治疗具有相同的疗效和安全性。
期刊:BMC Musculoskeletal Disorders
影响因子:2.4
doi:10.1186/s12891-017-1673-3
Wijesinghe, Harindu; Galappatthy, Priyadharshini; de Silva, Rajiva; Seneviratne, Suranjith L; Saravanamuttu, Ushagowry; Udagama, Preethi; Hart, Melanie; Kelleher, Peter; Senerath, Upul; Fernandopulle, Rohini; Weerasekera, Lilani P; Wijayaratne, Lalith S